Chase Investment Counsel’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.14M | Buy |
10,294
+2,349
| +30% | +$260K | 0.36% | 63 |
|
2025
Q1 | $890K | Hold |
7,945
| – | – | 0.33% | 72 |
|
2024
Q4 | $733K | Buy |
+7,945
| New | +$733K | 0.24% | 79 |
|
2022
Q1 | – | Sell |
-3,177
| Closed | -$230K | – | 126 |
|
2021
Q4 | $230K | Buy |
3,177
+28
| +0.9% | +$2.03K | 0.09% | 102 |
|
2021
Q3 | $219K | Buy |
3,149
+89
| +3% | +$6.19K | 0.09% | 96 |
|
2021
Q2 | $210K | Buy |
+3,060
| New | +$210K | 0.09% | 99 |
|
2016
Q2 | – | Sell |
-48,659
| Closed | -$4.47M | – | 102 |
|
2016
Q1 | $4.47M | Buy |
48,659
+385
| +0.8% | +$35.4K | 1.95% | 25 |
|
2015
Q4 | $4.88M | Sell |
48,274
-1,801
| -4% | -$182K | 1.95% | 22 |
|
2015
Q3 | $4.92M | Sell |
50,075
-1,735
| -3% | -$170K | 1.99% | 21 |
|
2015
Q2 | $6.07M | Sell |
51,810
-1,280
| -2% | -$150K | 2.21% | 13 |
|
2015
Q1 | $5.21M | Sell |
53,090
-9,138
| -15% | -$897K | 1.83% | 27 |
|
2014
Q4 | $5.87M | Sell |
62,228
-4,568
| -7% | -$431K | 2.09% | 14 |
|
2014
Q3 | $7.11M | Sell |
66,796
-13,708
| -17% | -$1.46M | 2.55% | 2 |
|
2014
Q2 | $6.67M | Sell |
80,504
-3,987
| -5% | -$331K | 2.26% | 6 |
|
2014
Q1 | $5.99M | Sell |
84,491
-17,919
| -17% | -$1.27M | 2.03% | 12 |
|
2013
Q4 | $7.69M | Sell |
102,410
-40,890
| -29% | -$3.07M | 2.28% | 5 |
|
2013
Q3 | $9.01M | Sell |
143,300
-1,300
| -0.9% | -$81.7K | 2.31% | 10 |
|
2013
Q2 | $7.41M | Buy |
+144,600
| New | +$7.41M | 1.98% | 23 |
|